Announcements
- Immuron Limited to Present at the Emerging Growth Conference
- Immuron Director Resignation
- Immuron to host Live Virtual Event
- Immuron Travelan® sales continued strong growth
- Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
- Immuron Presentation Australian Biologics Festival 2024
- Immuron achieves record Travelan® sales
- Immuron CEO, Steven Lydeamore Investor Webinar Presentation
- Immuron achieves record half yearly Travelan® sales
- Immuron Clinical Trials Update
More ▼
Key statistics
As of last trade, Immuron Ltd (ANW:FRA) traded at 0.0475, 50.79% above the 52 week low of 0.0315 set on Mar 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.0475 |
---|---|
High | 0.0475 |
Low | 0.0475 |
Bid | 0.0475 |
Offer | 0.0645 |
Previous close | 0.0495 |
Average volume | 0.00 |
---|---|
Shares outstanding | 228.00m |
Free float | 187.04m |
P/E (TTM) | -- |
Market cap | 21.20m AUD |
EPS (TTM) | -0.017 AUD |
Data delayed at least 15 minutes, as of May 23 2024 07:13 BST.
More ▼